Blueprint Genetics will be attending the Mitochondrial Medicine – Therapeutic Development Meeting
This meeting will take place on November 21–23, 2022, in the UK. This meeting will bring together leaders in the field of translational mitochondrial medicine, with a program designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in genomics, biochemistry, pathology and clinical medicine. For more information about the conference, click here.
A retrospective review of mitochondrial genome NGS analysis in 7000 rare disease patients
Presented by: EMEA Medical Advisor, Mari-Liis Lukke, PhD
Interested to learn more?
Our team is looking forward to meeting you!
Our Medical Advisor in EMEA, Mari-Liis Lukke, PhD, will be available to discuss all the latest updates from Blueprint Genetics! You can arrange a meeting with her by contacting her at email@example.com